ALS Nexus conference celebrates progress and community
This year's ALS Nexus conference allowed the community to connect with each other, celebrate recent advances, and share hope for the future.| ALS News Today
This year's ALS Nexus conference allowed the community to connect with each other, celebrate recent advances, and share hope for the future.| ALS News Today
Qalsody (tofersen) is conditionally approved in the U.S. as treatment for amyotrophic lateral sclerosis associated with SOD1 gene mutations.| ALS News Today
Marisa Wexler is a senior science writer for ALS News Today with an MS in cellular and molecular pathology. She covers the latest news and information on a variety of amyotrophic lateral sclerosis topics.| ALS News Today
Category archive page for News.| ALS News Today
ALS is a progressive neurological disorder that damages motor neurons. Learn more about types, causes, symptoms, diagnosis, and treatment.| ALS News Today
